• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素-蛋白酶体轴,尤其是泛素特异性蛋白酶17()基因家族,是高级别浆液性卵巢癌上皮-间质转化的潜在靶点。

Ubiquitin-Proteasome Axis, Especially Ubiquitin-Specific Protease-17 () Gene Family, is a Potential Target for Epithelial-Mesenchymal Transition in High-Grade Serous Ovarian Cancer.

作者信息

Yildirim Nuri, Kocal Gizem Calibasi, Isik Zerrin, Saatli Bahadır, Saygili Ugur, Uysal Tugba, Ulukus Cagnur, Koyuncuoglu Meral, Ellidokuz Hulya, Basbinar Yasemin

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ege University and Department of Basic Oncology, Dokuz Eylul University. Ege Üniversitesi Hastanesi, Kadın Hastalıkları ve Doğum AD, 35100, Bornova, Izmir, Turkey.

Basic Oncology, Institute of Medical Sciences, Dokuz Eylul University, Izmir, Turkey.

出版信息

Reprod Sci. 2019 Jun;26(6):794-805. doi: 10.1177/1933719118799189. Epub 2018 Sep 9.

DOI:10.1177/1933719118799189
PMID:30198418
Abstract

OBJECTIVES

To investigate gene expression differences and related functions between primary tumor, malignant cells in ascites, and metastatic peritoneal implant in high-grade serous ovarian cancer.

METHODS

Biopsies from primary tumor, peritoneal implant, and ascites were collected from 10 patients operated primarily for high-grade, advanced-staged serous ovarian cancer. Total RNA isolation was performed from collected tissue biopsy and fluid samples, and RNA expression profile was measured. Messenger RNA expression profiles of 3 different groups were compared. Functional analyses of candidate genes were carried out by gene ontology and pathway analysis.

RESULTS

There were significant differences in the expression of 5 genes between primary tumor and peritoneal implant, 979 genes between primary tumor and malignant cells in ascites, and 649 genes between peritoneal implant and malignant cells in ascites. Three commonly enriched gene ontology functions between "primary tumor and malignant cells in the ascites" and "peritoneal implant and malignant cells in the ascites" were protein deubiquitination, ubiquitin-dependent protein catabolism, and apoptotic processes. All genes related to these functions belonged to gene family.

CONCLUSION

Gene expression difference between primary tumor and the peritoneal implant is not as much as the difference between primary tumor and free cells in the ascites. These results show that malignant cells in the ascites return into its genetic origin after they invade on the peritoneum. Significantly increased expression of DUB-enzyme genes, gene family, and ribosomal pathway genes in epithelial-mesenchymal transition suggests that this regulation is ubiquitin-proteasome dependent. Especially, this is the first study that offers as a potential target for epithelial-mesenchymal transition.

摘要

目的

研究高级别浆液性卵巢癌中原发肿瘤、腹水中的恶性细胞以及腹膜转移种植灶之间的基因表达差异及相关功能。

方法

收集10例主要接受高级别、晚期浆液性卵巢癌手术患者的原发肿瘤、腹膜种植灶及腹水的活检样本。从收集的组织活检和液体样本中提取总RNA,并测量RNA表达谱。比较3个不同组的信使RNA表达谱。通过基因本体论和通路分析对候选基因进行功能分析。

结果

原发肿瘤与腹膜种植灶之间有5个基因表达存在显著差异,原发肿瘤与腹水中的恶性细胞之间有979个基因表达存在显著差异,腹膜种植灶与腹水中的恶性细胞之间有649个基因表达存在显著差异。“原发肿瘤与腹水中的恶性细胞”以及“腹膜种植灶与腹水中的恶性细胞”之间三个共同富集的基因本体功能是蛋白质去泛素化、泛素依赖性蛋白质分解代谢和凋亡过程。所有与这些功能相关的基因都属于基因家族。

结论

原发肿瘤与腹膜种植灶之间的基因表达差异不如原发肿瘤与腹水中游离细胞之间的差异大。这些结果表明,腹水中的恶性细胞在侵袭腹膜后恢复到其基因起源状态。上皮-间质转化中DUB酶基因、基因家族和核糖体通路基因的表达显著增加,表明这种调节是泛素-蛋白酶体依赖性的。特别是,这是第一项将作为上皮-间质转化潜在靶点的研究。

相似文献

1
Ubiquitin-Proteasome Axis, Especially Ubiquitin-Specific Protease-17 () Gene Family, is a Potential Target for Epithelial-Mesenchymal Transition in High-Grade Serous Ovarian Cancer.泛素-蛋白酶体轴,尤其是泛素特异性蛋白酶17()基因家族,是高级别浆液性卵巢癌上皮-间质转化的潜在靶点。
Reprod Sci. 2019 Jun;26(6):794-805. doi: 10.1177/1933719118799189. Epub 2018 Sep 9.
2
Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome.浆液性卵巢癌中的腹膜肿瘤播散——上皮-间质状态与预后
Oncotarget. 2015 Jul 10;6(19):17261-75. doi: 10.18632/oncotarget.3746.
3
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion.在卵巢癌细胞中上调间皮细胞基因与不良的临床结局相关,并促进癌细胞黏附。
Mol Oncol. 2020 Sep;14(9):2142-2162. doi: 10.1002/1878-0261.12749. Epub 2020 Jun 25.
4
Effect of ubiquitin-specific proteinase 43 on ovarian serous adenocarcinoma and its clinical significance.泛素特异性蛋白酶 43 对卵巢浆液性腺癌的影响及其临床意义。
J Obstet Gynaecol. 2024 Dec;44(1):2361862. doi: 10.1080/01443615.2024.2361862. Epub 2024 Jun 25.
5
ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.ZEB2 通过调节高级别浆液性卵巢癌中癌症干细胞样细胞的侵袭性和致瘤性促进腹膜转移。
Oncogene. 2021 Aug;40(32):5131-5141. doi: 10.1038/s41388-021-01913-3. Epub 2021 Jul 1.
6
Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.在浆液性积液的卵巢癌细胞中,白细胞介素-8和血管内皮生长因子的mRNA及蛋白质水平下调。
Clin Exp Metastasis. 2002;19(2):135-44. doi: 10.1023/a:1014582911680.
7
Molecular profiling and clinical outcome of high-grade serous ovarian cancer presenting with low- versus high-volume ascites.伴有少量与大量腹水的高级别浆液性卵巢癌的分子特征及临床结局
Biomed Res Int. 2014;2014:367103. doi: 10.1155/2014/367103. Epub 2014 May 25.
8
Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature.腹膜种植体的基因组异质性:使用 Nanostring 人类癌症参考面板进行基因表达的差异分析确定恶性特征。
Gynecol Oncol. 2020 Jan;156(1):6-12. doi: 10.1016/j.ygyno.2019.10.021. Epub 2019 Nov 8.
9
Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma.Akt2/ZEB2可能是晚期浆液性卵巢癌腹水中脱落细胞的一种生物标志物。
Tumour Biol. 2015 Sep;36(9):7213-9. doi: 10.1007/s13277-015-3437-8. Epub 2015 Apr 19.
10
Kindlin-2 inhibits serous epithelial ovarian cancer peritoneal dissemination and predicts patient outcomes.Kindlin-2 抑制浆液性上皮性卵巢癌腹膜转移并预测患者预后。
Biochem Biophys Res Commun. 2014 Mar 28;446(1):187-94. doi: 10.1016/j.bbrc.2014.02.087. Epub 2014 Feb 27.

引用本文的文献

1
Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis.卵巢癌中去泛素化酶的全球研究进展图谱与可视化:一项文献计量分析
Front Pharmacol. 2024 Sep 12;15:1445037. doi: 10.3389/fphar.2024.1445037. eCollection 2024.
2
Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.卵巢癌中循环肿瘤细胞的检测及循环肿瘤细胞上皮-间质转化模式的评估
Transl Cancer Res. 2022 Aug;11(8):2636-2646. doi: 10.21037/tcr-22-529.
3
Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis.

本文引用的文献

1
Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6.穹窿体RNA通过与RNA/DNA结合蛋白PSF结合并诱导癌基因GAGE6,部分诱导人肿瘤细胞MCF-7产生耐药性。
PLoS One. 2018 Jan 18;13(1):e0191325. doi: 10.1371/journal.pone.0191325. eCollection 2018.
2
Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells.长链非编码RNA snaR在HER2阳性乳腺癌细胞中的生物学功能
Tumour Biol. 2017 Jun;39(6):1010428317707374. doi: 10.1177/1010428317707374.
3
Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication.
多组学方法在探索卵巢癌发生分子机制中的应用
Front Oncol. 2021 Sep 24;11:745808. doi: 10.3389/fonc.2021.745808. eCollection 2021.
4
Tumor Suppressor Inhibits Oral Squamous Cell Carcinoma Cell Migration and Invasion Through the USP17-SNAI1 Axis.肿瘤抑制因子通过USP17-SNAI1轴抑制口腔鳞状细胞癌细胞的迁移和侵袭。
Front Oncol. 2020 Oct 29;10:559808. doi: 10.3389/fonc.2020.559808. eCollection 2020.
5
DUB3 Facilitates Growth and Inhibits Apoptosis Through Enhancing Expression of EZH2 in Oral Squamous Cell Carcinoma.DUB3通过增强EZH2在口腔鳞状细胞癌中的表达促进生长并抑制凋亡。
Onco Targets Ther. 2020 Feb 18;13:1447-1460. doi: 10.2147/OTT.S230577. eCollection 2020.
6
Down-regulation effects of IFN-α on p11, 5-htr1b and 5-HTR4 protein levels were affected by NHCL or MG132 treatment in SH-sy5y cells.IFN-α 对 p11、5-htr1b 和 5-HTR4 蛋白水平的下调作用受到 NHCL 或 MG132 处理对 SH-sy5y 细胞的影响。
J Biosci. 2019 Sep;44(4).
7
Deubiquitinase DUB3 Regulates Cell Cycle Progression via Stabilizing Cyclin A for Proliferation of Non-Small Cell Lung Cancer Cells.去泛素化酶 DUB3 通过稳定细胞周期蛋白 A 促进非小细胞肺癌细胞增殖调控细胞周期进程。
Cells. 2019 Mar 31;8(4):297. doi: 10.3390/cells8040297.
DUBs 在肿瘤转移和细胞凋亡中的新兴作用:治疗意义。
Pharmacol Ther. 2017 Sep;177:96-107. doi: 10.1016/j.pharmthera.2017.03.001. Epub 2017 Mar 6.
4
Long Noncoding RNA snaR Regulates Proliferation, Migration and Invasion of Triple-negative Breast Cancer Cells.长链非编码RNA snaR调节三阴性乳腺癌细胞的增殖、迁移和侵袭
Anticancer Res. 2016 Dec;36(12):6289-6295. doi: 10.21873/anticanres.11224.
5
Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells.核糖体蛋白L34促进胰腺癌细胞的增殖、侵袭和转移。
Oncotarget. 2016 Dec 20;7(51):85259-85272. doi: 10.18632/oncotarget.13269.
6
Suppression of Ubiquitin-Specific Peptidase 17 (USP17) Inhibits Tumorigenesis and Invasion in Non-Small Cell Lung Cancer Cells.泛素特异性肽酶17(USP17)的抑制作用可抑制非小细胞肺癌细胞的肿瘤发生和侵袭。
Oncol Res. 2016;24(4):263-9. doi: 10.3727/096504016X14666990347392.
7
Cell transfer technique for constructing cytological microarrays for immunocytochemical analysis.用于构建免疫细胞化学分析细胞学微阵列的细胞转移技术。
Cytopathology. 2017 Apr;28(2):157-163. doi: 10.1111/cyt.12360. Epub 2016 Aug 16.
8
MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes.MINDY-1是去泛素化酶新家族的成员,该家族在进化上保守且结构独特。
Mol Cell. 2016 Jul 7;63(1):146-55. doi: 10.1016/j.molcel.2016.05.009. Epub 2016 Jun 9.
9
Ubiquitin-Specific Proteases as Druggable Targets.泛素特异性蛋白酶作为可成药靶点
Drug Target Rev. 2015 Fall;2(3):60-64.
10
Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.泛素特异性蛋白酶 4 介导的 PRL-3 去泛素化和稳定作用对于促进结直肠肿瘤发生是必需的。
Cancer Res. 2016 Jan 1;76(1):83-95. doi: 10.1158/0008-5472.CAN-14-3595. Epub 2015 Dec 15.